311C90 - PATIENT PROFILES AND TYPICAL CASE-HISTORIES OF MIGRAINE MANAGEMENT

The 311C90 (Zomig; zolmitriptan) long-term safety and efficacy study i ncludes data from > 30,000 treated migraine attacks across > 2,000 pat ients. A review of the database identified individuals who were repres entative of the population studied within this trial to illustrate the findings from a patient perspective. Five case histories are describe d here. These patients were identified on the basis of lying at the mi dpoint of the trial population sample with reference to certain baseli ne characteristics, and therefore representing a ''typical'' patient. The case histories represent a ''typical'' man and woman patient, a pa tient who has migraine with aura, a patient with frequent migraine acc ompanied by a high frequency of adverse events, and a patient with fre quent migraine attacks, some of which were related to menses. The resu lts show that 311C90 was consistently effective for these individual p atients across a number of treated attacks in the acute treatment of m igraine. It is concluded that consideration of data at the individual patient level allows appreciation of clinical benefit from a different but valuable perspective.